Holding(s) in Company

AI SummaryClose X

NLC Ventures Netherlands B.V. has acquired a significant stake in Thalia Therapeutics PLC, crossing a notification threshold on July 20, 2026. The company now holds 14.47% of the voting rights, representing 256,893,337 ordinary shares. This marks a substantial increase from their previous holding of 0.00%.

Disclaimer*

UK 100

Latest directors dealings